Cleared Traditional

K023723 - FINOMETER NONINVASIVE HEMODYNAMIC MONITOR

K023723 is the FDA 510(k) clearance for FINOMETER NONINVASIVE HEMODYNAMIC MONITOR by Fms, Finapres Medical Systems BV. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 352-day FDA review.

K023723 · Fms, Finapres Medical Systems BV · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2003
Decision
352d
Days
Class 2
Risk

K023723 is an FDA 510(k) clearance for the FINOMETER NONINVASIVE HEMODYNAMIC MONITOR, MODEL 1. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Fms, Finapres Medical Systems BV (Santa Barbara, US). The FDA issued a Cleared decision on October 23, 2003 after a review of 352 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Fms, Finapres Medical Systems BV devices

Submission Details

510(k) Number K023723 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 05, 2002
Decision Date October 23, 2003
Days to Decision 352 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
227d slower than avg
Panel avg: 125d · This submission: 352d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 517
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K023723.
A&D MEDICAL LIFESOURCE DIGITAL BLOOD PRESSURE MONITORS, MODEL UB-328
K040229 · A&D Engineering, Inc. · Mar 2004
OMRON INTELLISENSE DIGITAL BLOOD PRESSURE MONITOR, MODEL HEM-907XL
K032305 · Omron Healthcare, Inc. · Feb 2004
A & D MEDICAL LIFESOURCE UA-704 DIGITAL BLOOD PRESSURE MONITORS
K032499 · A&D Engineering, Inc. · Oct 2003
HL888BM
K032837 · Health & Life Co., Ltd. · Oct 2003
HL888BA
K032839 · Health & Life Co., Ltd. · Oct 2003
MODIFICATION TO HL168
K033043 · Health & Life Co., Ltd. · Oct 2003